YAURVA Trademark

Trademark Overview


On Tuesday, July 18, 2023, a trademark application was filed for YAURVA with the United States Patent and Trademark Office. The USPTO has given the YAURVA trademark a serial number of 79378143. The federal status of this trademark filing is REGISTERED as of Tuesday, November 26, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The YAURVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevent...
yaurva

General Information


Serial Number79378143
Word MarkYAURVA
Filing DateTuesday, July 18, 2023
Status700 - REGISTERED
Status DateTuesday, November 26, 2024
Registration Number7574776
Registration DateTuesday, November 26, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 24, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations, namely, for treatment of immunological diseases, and treatment of infectious diseases; all aforementioned goods except for the prevention and treatment of oncological diseases.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Wednesday, September 13, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Saturday, February 17, 2024LIMITATION OF GOODS RECEIVED FROM IB
Friday, March 8, 2024ASSIGNED TO EXAMINER
Thursday, September 7, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 19, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, March 12, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 11, 2024LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Monday, March 11, 2024NON-FINAL ACTION WRITTEN
Friday, March 29, 2024REFUSAL PROCESSED BY MPU
Tuesday, August 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 29, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 24, 2024REFUSAL PROCESSED BY IB
Monday, May 20, 2024LIMITATION OF GOODS RECEIVED FROM IB
Saturday, July 13, 2024LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, August 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 24, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 24, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, February 26, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, March 1, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, December 6, 2024LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, December 6, 2024LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, February 8, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, February 10, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 23, 2025FINAL DISPOSITION PROCESSED
Wednesday, April 23, 2025FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 9, 2025FINAL DECISION TRANSACTION PROCESSED BY IB